您当前的位置:
PD98059.
目录号: PC11746 纯度: ≥98%
CAS No. :167869-21-8
商品编号 规格 价格 会员价 是否有货 数量
PC11746-10mg 10mg ¥490.00 请登录
PC11746-50mg 50mg ¥1078.00 请登录
PC11746-100mg 100mg ¥1862.00 请登录
PC11746-10mM (in 1mL DMSO) 10mM (in 1mL DMSO) ¥539.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
PD98059.
中文别名
2-(2-氨基-3-甲氧苯基)色酮;PD 098,059 (2-(2-氨基-3-甲氧基苯基)- 4H-1-苯吡喃-4-酮;1,3,5-环己三酸;2-(2-Amino-3-methoxyphenyl)chromone 2-(2-氨基-3-甲氧苯基)色酮;2-(2-氨基-3-甲氧基苯基)-4H-1-苯并吡喃-4-酮;MEK1抑制剂(PD98059);PD98059 抑制剂;2-(2-氨基-3-甲氧苯基)-4H-1-苯并呋喃-4-酮;2-(2-氨基-3-甲氧苯基)-4H-1-苯并吡喃-4-酮;2-(2-氨基-3-甲氧基苯基)-4H-1-苯并吡喃-4-酮, 一种非ATP竞争性的MEK抑制剂
英文名称
PD98059
英文别名
2-(2-Amino-3-methoxyphenyl)-4H-chromen-4-one;2-(2-Amino-3-methoxyphenyl)chromone;2-(2-amino-3-methoxyphenyl)chromen-4-one;4H-1-Benzopyran-4-one,2-(2-amino-3-methoxyphenyl)-;PD 98059 (PD98059,PD 0980599);PD-98059;2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one;2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one PD98059;2-(2-Amino-3-methoxyphenyl)-chromen-4-one;2'-AMINO-3'-METHOXYFLAVONE;4H-1-Benzopyran-4-one,2-(2-Amino-3-methoxyphenyl);PD 98059;PD090859;PD 098,059;PD 98059 in Solution;InSolution? PD 98059;PD98059;PD 98059, 99+%;PD 98059, >=98%;PD-98059/PD98059;PD 98,059;SJE1IO5E3I;4H-1-Benzopyran-4-one, 2-(2-Amino-3-methoxyphenyl)-;2′-Amino-3′-methoxyflavone;2-(2-amino-3-methoxy-phenyl)chromen-4-one;2-(2-Amino-3-methoxy-ph
Cas No.
167869-21-8
分子式
C16H13NO3
分子量
267.28
包装储存

Sealed and stored at 4℃

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

生物活性

PD98059 is a potent and selective MEK inhibitor with an IC50 of 5 μM. PD98059 binds to the inactive form of MEK, thereby preventing the activation of MEK1 (IC50 of 2-7 μM) and MEK2 (IC50 of 50 μM) by upstream kinases. PD98059 is a ERK1/2 signaling inhibitor. PD98059 is a ligand for the aryl hydrocarbon receptor (AHR), and suppresses TCDD binding (IC50 of 4 μM) and AHR transformation (IC50 of 1 μM). PD98059 also inhibits Mycobacterium bovis Bacillus CalmetteGuerin (BCG)-induced autophagy.

性状

Solid

IC50 & Target[1][2]

MEK1

2-7 μM (IC50)

MEK2

50 μM (IC50)

ERK1

 

ERK2

 

Autophagy

 

体外研究(In Vitro)

PD98059 (20 μM; 24 hours) causes G1-phase cell cycle arrest in OCI-AML-3 cells.
PD98059 (10 μM; 22 hours) results in concentration-dependent reductions in the dually phosphorylated forms of ERK1 and ERK2. PD98059 both prevents ERK activation and blocks formation of TDP-43 and HuR-positive SGs.

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cycle Analysis

Cell Line: OCI-AML-3 cells
Concentration: 20 μM
Incubation Time: 24 hours
Result: Caused G1-phase cell cycle arrest.

Western Blot Analysis

Cell Line: MCF10A-Neo, MCF10ANeoT cells
Concentration: 10 μM
Incubation Time: 22 hours
Result: Phosphorylated ERK forms were almost completely eliminated in both cell lines.
体内研究(In Vivo)

PD98059 (10 mg/kg; i.p.; 1 and 6 hours after Zymosan) significantly reduces the level of p-ERK1/2 in zymosan-injected mice.

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male CD mice
Dosage: 10 mg/kg
Administration: Intraperitoneal injection; 1 and 6 hours after Zymosan
Result: Significantly reduced the level of p-ERK1/2.
运输条件

Room temperature or refrigerated transportation.

储存方式

Sealed and stored at 4℃

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

参考文献
溶解度数据
体外研究: 

DMSO : 33.33 mg/mL (124.70 mM; Need ultrasonic)

H2O : < 0.1 mg/mL (insoluble)

配制储备溶液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 3.7414 mL 18.7070 mL 37.4139 mL
5 mM 0.7483 mL 3.7414 mL 7.4828 mL
10 mM 0.3741 mL 1.8707 mL 3.7414 mL
*

产品不同,其溶解度不同。建议根据产品选择合适的溶剂配制储备溶液;配成溶液后,建议分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C 储存时,建议在 6 个月内使用,-20°C 储存时,建议在 1 个月内使用。

体内研究:

建议根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都建议先按照 体外研究 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    建议依照次序添加每种溶剂: 50% PEG300    50% saline

    Solubility: 10 mg/mL (37.41 mM); Suspended solution; Need ultrasonic

  • 2.

    建议依照次序添加每种溶剂: 10% DMSO    90% (20% SBE-β-CD in saline)

    Solubility: 2.08 mg/mL (7.78 mM); Suspended solution; Need ultrasonic

    此方案可获得 2.08 mg/mL (7.78 mM) 的均匀悬浊液,悬浊液可用于口服和腹腔注射。

    以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中,混合均匀。

    将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中,再用生理盐水定容至 10 mL,完全溶解,澄清透明
*
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2